What is Quantificare?
Quantificare specializes in providing standardized imaging solutions, project management, and sophisticated image analysis tailored for clinical studies. Their expertise extends to aesthetic photography for dermatologists and aesthetic specialists, enhancing the efficacy and safety of treatments through objective and validated imaging systems. Operating internationally, Quantificare leverages innovative mobile technology and high-quality imaging equipment, including the LifeViz series, to support research and clinical practice.
How much funding has Quantificare raised?
Quantificare has raised a total of $4M across 1 funding round:
Other Financing Round
$4M
Other Financing Round (2019): $4M with participation from LBO France
Key Investors in Quantificare
LBO France
LBO France is a seasoned private equity firm with over three decades of experience, focusing on LBO Mid Cap, LBO Small Cap, real estate, and digital health. Managing approximately €2.5 billion, the firm integrates ESG and climate initiatives into its investment strategy, aiming to create operational value and impact across Europe and Africa.
What's next for Quantificare?
With its recent major strategic investment, Quantificare is poised to further solidify its market position and expand its technological capabilities. The substantial capital infusion, contextualized by its overall funding history, suggests a strategic focus on scaling operations, enhancing research and development in imaging analytics, and potentially broadening its service offerings to a wider range of medical and aesthetic applications. This backing will likely fuel the company's mission to drive objective insights in treatment evaluation.
See full Quantificare company page
